Home/Filings/4/0000899243-23-014886
4//SEC Filing

Sandoval Elisabeth 4

Accession 0000899243-23-014886

CIK 0001692830other

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:38 PM ET

Size

13.2 KB

Accession

0000899243-23-014886

Insider Transaction Report

Form 4
Period: 2023-06-08
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-06-0820,0000 total
    Exercise: $4.60Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-06-0810,0000 total
    Exercise: $26.99Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-06-0830,0000 total
    Exercise: $3.46Common Stock (30,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2023-06-0814,8930 total
    Exercise: $4.56Common Stock (14,893 underlying)
Footnotes (2)
  • [F1]Pursuant to the Merger Agreement, each vested option to purchase shares of common stock, par value $0.0001 per share (the "Shares") of the Issuer, with an exercise price that is less than the purchase price of $0.91 per share (the "Offer Price"), that is outstanding immediately prior to the date and time at which the Merger became effective (the "Effective Time") will terminate and be cancelled immediately prior to the Effective Time and converted into the right to receive (a) one non-transferable contractual contingent value right and (b) a lump sum cash payment equal in amount to (i) the number of vested Shares underlying such vested option as of immediately prior to the Effective Time, multiplied by (ii) the excess, if any, of $0.91 over the exercise price per Share underlying such vested option, less any required withholding taxes.
  • [F2]Pursuant to the Merger Agreement, each option that was not a vested option to purchase Shares of the Issuer with an exercise price that is less than the Offer Price and was outstanding immediately prior to the Effective Time was terminated and cancelled immediately prior to the Effective Time for no consideration.

Issuer

Satsuma Pharmaceuticals, Inc.

CIK 0001692830

Entity typeother

Related Parties

1
  • filerCIK 0001632295

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:38 PM ET
Size
13.2 KB